Cite

    Tidmore, L. et al. (2022). Readmissions, costs, and duration to subsequent outpatient visit after hospital discharge among Medicaid beneficiaries utilizing oral versus long-acting injectable antipsychotics in bipolar disorder or schizophrenia. Current medical research and opinion. pp. 1621-1630. [Online].